Preelinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease
Preelinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease
复制标题
DOI:
10.2174/156720506775697160
复制
发表时间:
2006-02-01
影响因子:
2.1
通讯作者:
Wang, Jun Ming
中科院分区:
文献类型:
--
作者:
Brinton, Roberta Diaz;Wang, Jun Ming
Herein, we present data to support a preclinical proof of concept for the therapeutic potential of allopregnanolone to promote neurogenesis. Our recent work has demonstrated that the neuroactive progesterone metabolite, allopregnanolone (3 alpha-hydroxy-5 alpha-pregnan-20-one), (AP alpha) induced, in a dose dependent manner, a significant increase in proliferation of neuroprogenitor cells (NPCs) derived from tile rat hippocampus and human neural stein cells (hNSM) derived from, the cerebral cortex [1]. Proliferative efficacy was determined by incorporation of BrdU and H-3-thymidine, FACS analysis of MuLV-GFP-labeled mitotic NPCs and quantification of total Cell number. Allopregnanolone-induced proliferation was isomer and steroid specific, in that the stereoisomer 3 beta-hydroxy-5 beta-pregnan-20-one and related steroids did not increase H-3-thymidine uptake. Immunofluorescent analyses for the NPC markers, nestin and Tuj1, indicated that newly formed cells were of neuronal lineage. Furthermore, microarray analysis of cell cycle genes and real time RT-PCR and western blot validation revealed that allopregnanolone increased tile expression of genes which promote mitosis and inhibited the expression of genes that repress cell proliferation. Allopregnanolone-induced proliferation was antagonized by the voltage gated L-type calcium channel blocker nifedipine consistent with the finding that allopregnanolone induces a rapid increase in intracellular calcium in hippocampal neurons via a GABA type A receptor activated L-type calcium channel. Preliminary it? vivo data indicate that APa for 24 hrs significantly increased neurogenesis in dentate gyros, as determined by unbiased stereological analysis of BrdU positive cells, of 3-month-old male triple transgenic Alzheimer's disease mice. The in vitro and in vivo neurogenic properties of AP alpha coupled with a low molecular weight, easy penetration of the blood brain barrier and lack of toxicity, are key elements required for developing AP alpha as a neurogenic/regenerative therapeutic for restoration of neurons in victims of Alzheimer's disease.